placebo without baseline insulin. In pooled analyses, researchers found that treatment with any new diabetes drug but without insulin for type 2 diabetes was associated with CV benefit compared with placebo with no insulin at baseline (pooled RR = 0.85
Researchers at University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat diabetes and obesity, may help reduce liver scarring in patients with advanced fatty liver disease, including those with early-stage cirrhosis
One study compared methylene blue in a single dose of 1mg/kg 30 minutes after injury to administration of that same dose 30 minutes after injury and then once monthly for a total of 6 months
She really took her time to explain and listen to all my concerns
For now, I use it in morning and evening care
Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells